Abstract
Periodontitis is a prevalent oral chronic inflammatory disease which, in severe forms, may exert a major impact on systemic health. Clinical and histological observations, as well as experimental animal studies, suggest involvement of the complement system in periodontitis. However, the precise roles of the various complement components and pathways in periodontitis have only recently started to be elucidated. In this chapter, we review recent progress in the field and discuss the potential of complement-targeted therapeutics in the treatment of periodontitis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Armitage GC (2002) Classifying periodontal diseases – a long-standing dilemma. Periodontol 2000 30:9–23
Bamberg CE, Mackay CR, Lee H, Zahra D, Jackson J, Lim YS, Whitfeld PL, Craig S, Corsini E, Lu B, Gerard C, Gerard NP (2010) The C5a receptor (C5aR) C5L2 is a modulator of C5aR-mediated signal transduction. J Biol Chem 285:7633–7644
Beikler T, Peters U, Prior K, Eisenacher M, Flemmig TF (2008) Gene expression in periodontal tissues following treatment. BMC Med Genomics 1:30
Brown LJ, Johns BA, Wall TP (2002) The economics of periodontal diseases. Periodontol 2000 29:223–234
Brown JH, Whitham TG, Morgan Ernest SK, Gehring CA (2001) Complex species interactions and the dynamics of ecological systems: long-term experiments. Science 293:643–650
Burns E, Bachrach G, Shapira L, Nussbaum G (2006) Cutting edge: TLR2 is required for the innate response to Porphyromonas gingivalis: activation leads to bacterial persistence and TLR2 deficiency attenuates induced alveolar bone resorption. J Immunol 177:8296–8300
Chai L, Song Y-Q, Zee K-Y, Leung WK (2010) Single nucleotide polymorphisms of complement component 5 and periodontitis. J Periodont Res 45:301–308
Chang M, Rowland CM, Garcia VE, Schrodi SJ, Catanese JJ, van der Helm-van Mil AH, Ardlie KG, Amos CI, Criswell LA, Kastner DL, Gregersen PK, Kurreeman FA, Toes RE, Huizinga TW, Seldin MF, Begovich AB (2008) A large-scale rheumatoid arthritis genetic study identifies association at chromosome 9q33.2. PLoS Genet 4:e1000107
Coats SR, Jones JW, Do CT, Braham PH, Bainbridge BW, To TT, Goodlett DR, Ernst RK, Darveau RP (2009) Human toll-like receptor 4 responses to P. gingivalis are regulated by lipid A 1- and 4′-phosphatase activities. Cell Microbiol 11:1587–1599
Courts FJ, Boackle RJ, Fudenberg HH, Silverman MS (1977) Detection of functional complement components in gingival crevicular fluid from humans with periodontal diseases. J Dent Res 56:327–331
de Haas CJC, Veldkamp KE, Peschel A, Weerkamp F, Van Wamel WJB, Heezius ECJM, Poppelier MJJG, Van Kessel KPM, van Strijp JAG (2004) Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent. J Exp Med 199:687–695
de Pablo P, Chapple IL, Buckley CD, Dietrich T (2009) Periodontitis in systemic rheumatic diseases. Nat Rev Rheumatol 5:218–224
Delima AJ, Van Dyke TE (2003) Origin and function of the cellular components in gingival crevice fluid. Periodontol 2000 31:55–76
Dunkelberger JR, Song WC (2010) Complement and its role in innate and adaptive immune responses. Cell Res 20:34–50
Ebenman B, Jonsson T (2005) Using community viability analysis to identify fragile systems and keystone species. Trends Ecol Evol 20:568–575
Gaffen SL, Hajishengallis G (2008) A new inflammatory cytokine on the block: re-thinking periodontal disease and the Th1/Th2 paradigm in the context of Th17 cells and IL-17. J Dent Res 87:817–828
Genco RJ, Van Dyke TE (2010) Prevention: reducing the risk of CVD in patients with periodontitis. Nat Rev Cardiol 7:479–480
Gibson FC III, Yumoto H, Takahashi Y, Chou HH, Genco CA (2006) Innate immune signaling and Porphyromonas gingivalis-accelerated atherosclerosis. J Dent Res 85:106–121
Graves D (2008) Cytokines that promote periodontal tissue destruction. J Periodontol 79:1585–1591
Guo RF, Ward PA (2005) Role of C5a in inflammatory responses. Annu Rev Immunol 23:821–852
Hajishengallis G (2009a) Porphyromonas gingivalis-host interactions: open war or intelligent guerilla tactics? Microbes Infect 11:637–645
Hajishengallis G (2009b) Toll gates to periodontal host modulation and vaccine therapy. Periodontol 2000 51:181–207
Hajishengallis G (2010) Complement and periodontitis. Biochem Pharmacol 80:1992–2001
Hajishengallis G, Lambris JD (2010) Crosstalk pathways between Toll-like receptors and the complement system. Trends Immunol 31:154–163
Hajishengallis G, Lambris JD (2011) Microbial manipulation of receptor crosstalk in innate immunity. Nat Rev Immunol 11:187–200
Hajishengallis G, Shakhatreh M-AK, Wang M, Liang S (2007) Complement receptor 3 blockade promotes IL-12-mediated clearance of Porphyromonas gingivalis and negates its virulence in vivo. J Immunol 179:2359–2367
Hajishengallis G, Wang M, Liang S, Triantafilou M, Triantafilou K (2008) Pathogen induction of CXCR4/TLR2 cross-talk impairs host defense function. Proc Natl Acad Sci USA 105:13532–13537
Hajishengallis G, Liang S, Payne MA, Hashim A, Jotwani R, Eskan MA, McIntosh ML, Alsam A, Kirkwood KL, Lambris JD, Darveau RP, Curtis MA (2011) Low-abundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement. Cell Host Microbe 10:497–506
Harboe M, Mollnes TE (2008) The alternative complement pathway revisited. J Cell Mol Med 12:1074–1084
Hillebrandt S, Wasmuth HE, Weiskirchen R, Hellerbrand C, Keppeler H, Werth A, Schirin-Sokhan R, Wilkens G, Geier A, Lorenzen J, Kohl J, Gressner AM, Matern S, Lammert F (2005) Complement factor 5 is a quantitative trait gene that modifies liver fibrogenesis in mice and humans. Nat Genet 37:835–843
Holers VM (2008) The spectrum of complement alternative pathway-mediated diseases. Immunol Rev 223:300–316
Kanazawa N, Furukawa F (2007) Autoinflammatory syndromes with a dermatological perspective. J Dermatol 34:601–618
Kasama T, Miwa Y, Isozaki T, Odai T, Adachi M, Kunkel SL (2005) Neutrophil-derived cytokines: potential therapeutic targets in inflammation. Curr Drug Targets Inflamm Allergy 4:273–279
Kebschull M, Demmer RT, Papapanou PN (2010) “Gum bug leave my heart alone” – epidemiologic and mechanistic evidence linking periodontal infections and atherosclerosis. J Dent Res 89:879–902
Kimura Y, Miwa T, Zhou L, Song W-C (2008) Activator-specific requirement of properdin in the initiation and amplification of the alternative pathway complement. Blood 111:732–740
Kinane DF, Peterson M, Stathopoulou PG (2006) Environmental and other modifying factors of the periodontal diseases. Periodontol 2000 40:107–119
Kitsis E, Weissmann G (1991) The role of the neutrophil in rheumatoid arthritis. Clin Orthop Relat Res 265:63–72
Krauss JL, Potempa J, Lambris JD, Hajishengallis G (2010) Complementary tolls in the periodontium: how periodontal bacteria modify complement and Toll-like receptor responses to prevail in the host. Periodontol 2000 52:141–162
Kumpf O, Schumann RR (2008) Genetic influence on bloodstream infections and sepsis. Int J Antimicrob Agents 32(Suppl 1):S44–S50
Lange D, Schroeder HE (1971) Cytochemistry and ultrastructure of gingival sulcus cells. Helv Odontol Acta 15:65–86
Liang S, Krauss JL, Domon H, McIntosh ML, Hosur KB, Qu H, Li F, Tzekou A, Lambris JD, Hajishengallis G (2011) The C5a receptor impairs IL-12-dependent clearance of Porphyromonas gingivalis and is required for induction of periodontal bone loss. J Immunol 186:869–877
Newman HN (1980) Neutrophils and IgG at the host-plaque interface on children’s teeth. J Periodontol 51:642–651
Niekrash CE, Patters MR (1986) Assessment of complement cleavage in gingival fluid in humans with and without periodontal disease. J Periodont Res 21:233–242
Nikolopoulou-Papaconstantinou AA, Johannessen AC, Kristoffersen T (1987) Deposits of immunoglobulins, complement, and immune complexes in inflamed human gingiva. Acta Odontol Scand 45:187–193
Nussbaum G, Shapira L (2011) How has neutrophil research improved our understanding of periodontal pathogenesis? J Clin Periodontol 38:49–59
Okroj M, Heinegard D, Holmdahl R, Blom AM (2007) Rheumatoid arthritis and the complement system. Ann Med 39:517–530
Okuda K, Kimizuka R, Abe S, Kato T, Ishihara K (2005) Involvement of periodontopathic anaerobes in aspiration pneumonia. J Periodontol 76:2154–2160
Patters MR, Niekrash CE, Lang NP (1989) Assessment of complement cleavage in gingival fluid during experimental gingivitis in man. J Clin Periodontol 16:33–37
Pihlstrom BL, Michalowicz BS, Johnson NW (2005) Periodontal diseases. Lancet 366:1809–1820
Popadiak K, Potempa J, Riesbeck K, Blom AM (2007) Biphasic effect of gingipains from Porphyromonas gingivalis on the human complement system. J Immunol 178:7242–7250
Potempa J, Pike RN (2009) Corruption of innate immunity by bacterial proteases. J Innate Immun 1:70–87
Power ME, Tilman D, Estes JA, Menge BA, Bond WJ, Mills LS, Daily G, Castilla JC, Lubchenco J, Paine RT (1996) Challenges in the quest for keystones. Bioscience 46:609–620
Rautemaa R, Meri S (1996) Protection of gingival epithelium against complement-mediated damage by strong expression of the membrane attack complex inhibitor protectin (CD59). J Dent Res 75:568–574
Ricklin D, Lambris JD (2007) Complement-targeted therapeutics. Nat Biotechnol 25:1265–1275
Ricklin D, Hajishengallis G, Yang K, Lambris JD (2010) Complement: a key system for immune surveillance and homeostasis. Nat Immunol 11:785–797
Roberts A, Shah M, Chapple IL (2003) C-1 esterase inhibitor dysfunction localised to the periodontal tissues: clues to the role of stress in the pathogenesis of chronic periodontitis? J Clin Periodontol 30:271–277
Scannapieco FA, Dasanayake AP, Chhun N (2010) Does periodontal therapy reduce the risk for systemic diseases? Dent Clin North Am 54:163–181
Schenkein HA, Genco RJ (1977) Gingival fluid and serum in periodontal diseases. II. Evidence for cleavage of complement components C3, C3 proactivator (factor B) and C4 in gingival fluid. J Periodontol 48:778–784
Schroeder HE, Listgarten MA (1997) The gingival tissues: the architecture of periodontal protection. Periodontol 2000 13:91–120
Seppanen M, Lokki ML, Notkola IL, Mattila K, Valtonen V, Nieminen A, Vesanen M, Asikainen S, Meri S (2007) Complement and c4 null alleles in severe chronic adult periodontitis. Scand J Immunol 65:176–181
Serhan CN, Chiang N, Van Dyke TE (2008) Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 8:349–361
Simpson JL, Phipps S, Gibson PG (2009) Inflammatory mechanisms and treatment of obstructive airway diseases with neutrophilic bronchitis. Pharmacol Ther 124:86–95
Slaney JM, Curtis MA (2008) Mechanisms of evasion of complement by Porphyromonas gingivalis. Front Biosci 13:188–196
Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL Jr (1998) Microbial complexes in subgingival plaque. J Clin Periodontol 25:134–144
Spitzer D, Mitchell LM, Atkinson JP, Hourcade DE (2007) Properdin can initiate complement activation by binding specific target surfaces and providing a platform for de novo convertase assembly. J Immunol 179:2600–2608
Tonetti MS, D’Aiuto F, Nibali L, Donald A, Storry C, Parkar M, Suvan J, Hingorani AD, Vallance P, Deanfield J (2007) Treatment of periodontitis and endothelial function. N Engl J Med 356:911–920
Vitkov L, Klappacher M, Hannig M, Krautgartner WD (2010) Neutrophil fate in gingival crevicular fluid. Ultrastruct Pathol 34:25–30
Wagner E, Frank MM (2010) Therapeutic potential of complement modulation. Nat Rev Drug Discov 9:43–56
Wang M, Shakhatreh M-AK, James D, Liang S, S-i N, Yoshimura F, Demuth DR, Hajishengallis G (2007) Fimbrial proteins of Porphyromonas gingivalis mediate in vivo virulence and exploit TLR2 and complement receptor 3 to persist in macrophages. J Immunol 179:2349–2358
Wang M, Krauss JL, Domon H, Hosur KB, Liang S, Magotti P, Triantafilou M, Triantafilou K, Lambris JD, Hajishengallis G (2010) Microbial hijacking of complement-toll-like receptor crosstalk. Sci Signal 3:ra11
Ward PA (2009) Functions of C5a receptors. J Mol Med 87:375–378
Wingrove JA, DiScipio RG, Chen Z, Potempa J, Travis J, Hugli TE (1992) Activation of complement components C3 and C5 by a cysteine proteinase (gingipain-1) from Porphyromonas (Bacteroides) gingivalis. J Biol Chem 267:18902–18907
Zhang X, Kimura Y, Fang C, Zhou L, Sfyroera G, Lambris JD, Wetsel RA, Miwa T, Song WC (2007) Regulation of Toll-like receptor-mediated inflammatory response by complement in vivo. Blood 110:228–236
Zhang X, Schmudde I, Laumonnier Y, Pandey MK, Clark JR, Konig P, Gerard NP, Gerard C, Wills-Karp M, Kohl J (2010) A critical role for C5L2 in the pathogenesis of experimental allergic asthma. J Immunol 185:6741–6752
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Hajishengallis, G., Lambris, J.D. (2013). Complement-Targeted Therapeutics in Periodontitis. In: Lambris, J., Holers, V., Ricklin, D. (eds) Complement Therapeutics. Advances in Experimental Medicine and Biology, vol 735. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-4118-2_13
Download citation
DOI: https://doi.org/10.1007/978-1-4614-4118-2_13
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-4117-5
Online ISBN: 978-1-4614-4118-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)